ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding ProMIS Neurosciences Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 13 | 14 | +1 |
| Shares | 186.6K | 2.81M | +2.62M (+1,403.5%) |
| Value | $723.8K | $5.61M | +$4.89M (+675.1%) |
New holders (3)
Institutions that held ProMIS Neurosciences Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sphera Funds Management Ltd. | 1,834,042 | $3.69M | 0.88% |
| Ally Bridge Group (NY) LLC | 531,915 | $1.05M | 1.24% |
| Affinity Asset Advisors, LLC | 265,958 | $526.7K | 0.17% |
Sold out (2)
Institutions that held ProMIS Neurosciences Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Morgan Stanley | 1,808 | $7.01K |
| Gables Capital Management Inc. | 833 | $3.23K |